HLA-G and Parkinson disease: Collectively, these findings highlight a spectrum of renal biomarkers, including eGFR, creatinine, BUN, β2‐microglobulin, and albuminuria, that may provide clinically meaningful insights into PD risk and progression, and pave the way for mechanistic exploration of the kidney–brain axis in PD.